143 related articles for article (PubMed ID: 6534831)
21. The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.
Kahn A; Marie J; Garreau H; Sprengers ED
Biochim Biophys Acta; 1978 Mar; 523(1):59-74. PubMed ID: 629993
[TBL] [Abstract][Full Text] [Related]
22. Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism.
Friesen RH; Castellani RJ; Lee JC; Braun W
Biochemistry; 1998 Nov; 37(44):15266-76. PubMed ID: 9799487
[TBL] [Abstract][Full Text] [Related]
23. Mathematical modelling of metabolic pathways affected by an enzyme deficiency. A mathematical model of glycolysis in normal and pyruvate-kinase-deficient red blood cells.
Holzhütter HG; Jacobasch G; Bisdorff A
Eur J Biochem; 1985 May; 149(1):101-11. PubMed ID: 3996397
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel allosteric regulators of human-erythrocyte pyruvate kinase.
Kharalkar SS; Joshi GS; Musayev FN; Fornabaio M; Abraham DJ; Safo MK
Chem Biodivers; 2007 Nov; 4(11):2603-17. PubMed ID: 18027374
[TBL] [Abstract][Full Text] [Related]
25. Decrease in L-type pyruvate kinase activity in rat liver by some promoters of hepatocarcinogenesis.
Yanagi S; Sakamoto M; Ninomiya Y; Kamiya T
J Natl Cancer Inst; 1984 Oct; 73(4):887-94. PubMed ID: 6592385
[TBL] [Abstract][Full Text] [Related]
26. Diminution of stationary enzyme activities at increases of pyruvate kinase concentration in a reconstituted enzyme system.
Schellenberger W; Eschrich K; Hofmann E
Biomed Biochim Acta; 1983; 42(1):57-72. PubMed ID: 6224485
[TBL] [Abstract][Full Text] [Related]
27. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
[TBL] [Abstract][Full Text] [Related]
28. Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities.
Mehta M; Sonawat HM; Sharma S
J Vector Borne Dis; 2006 Sep; 43(3):95-103. PubMed ID: 17024857
[TBL] [Abstract][Full Text] [Related]
29. Pyruvate kinase activity in the placentas of women living in polluted and unpolluted environments.
Kedryna T; Gumińska M; Lucyna Z
Med Sci Monit; 2004 Dec; 10(12):CR672-8. PubMed ID: 15567985
[TBL] [Abstract][Full Text] [Related]
30. Kinetic, dynamic, and pathway studies of glycerol metabolism by Klebsiella pneumoniae in anaerobic continuous culture: IV. Enzymes and fluxes of pyruvate metabolism.
Menzel K; Ahrens K; Zeng A; Deckwer W
Biotechnol Bioeng; 1998 Dec; 60(5):617-26. PubMed ID: 10099470
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase.
Wooll JO; Friesen RH; White MA; Watowich SJ; Fox RO; Lee JC; Czerwinski EW
J Mol Biol; 2001 Sep; 312(3):525-40. PubMed ID: 11563914
[TBL] [Abstract][Full Text] [Related]
32. Pyruvate kinase isozyme (PK-Greenville) with defective allosteric activation by fructose-1,6-diphosphate: the role of F-1,6-P modulation in normal erythrocyte metabolism.
Paglia DE; Valentine WN; Holbrook CT; Brockway R
Blood; 1983 Nov; 62(5):972-9. PubMed ID: 6626748
[TBL] [Abstract][Full Text] [Related]
33. Mathematical modelling of metabolic pathways affected by an enzyme deficiency.
Holzhütter HG; Schuster R; Buckwitz D; Jacobasch G
Biomed Biochim Acta; 1990; 49(8-9):791-800. PubMed ID: 2082922
[TBL] [Abstract][Full Text] [Related]
34. Developmental changes of mouse red cell pyruvate kinase.
Gilman JG; Jenkins GM
Biomed Biochim Acta; 1983; 42(11-12):S273-7. PubMed ID: 6675702
[TBL] [Abstract][Full Text] [Related]
35. Comparison of pyruvate kinase variants from rat liver and Morris hepatoma 7777, obtained by an affinity chromatography on blue sepharose CL-6B.
Ignacak J; Gumińska M
Acta Biochim Pol; 1993; 40(2):261-7. PubMed ID: 8212964
[TBL] [Abstract][Full Text] [Related]
36. Conversion of pyruvate kinase (PK) isozymes during development of normal and PK deficient erythroblasts.
Miwa S; Takegawa S
Biomed Biochim Acta; 1983; 42(11-12):S242-6. PubMed ID: 6675697
[TBL] [Abstract][Full Text] [Related]
37. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of novel mutations in the human PKLR gene in pyruvate kinase-deficient Indian patients with heterogeneous clinical phenotypes.
Kedar P; Hamada T; Warang P; Nadkarni A; Shimizu K; Fujji H; Ghosh K; Kanno H; Colah R
Clin Genet; 2009 Feb; 75(2):157-62. PubMed ID: 18759866
[TBL] [Abstract][Full Text] [Related]
39. The ATP level and pyruvate kinase activity in dog red cells.
Jabłońska-Skwiecińska E; Sawicka B; Kłopocka J
Acta Physiol Pol; 1980; 31(1):31-4. PubMed ID: 7376896
[TBL] [Abstract][Full Text] [Related]
40. In silico-screening approaches for lead generation: identification of novel allosteric modulators of human-erythrocyte pyruvate kinase.
Tripathi A; Safo MK
Methods Mol Biol; 2012; 796():351-67. PubMed ID: 22052500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
